PIA
NVS icon

Philadelphia International Advisors’s Novartis NVS Stock Holding History

Philadelphia International Advisors’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-98,744
Closed -$8.2M – 74
2014
Q4 		$8.2M Sell
98,744
-926
-0.9% -$76.8K 2.44% 5
2014
Q3 		$8.41M Sell
99,670
-8,347
-8% -$675K 2.16% 8
2014
Q2 		$8.76M Sell
108,017
-8,144
-7% -$641K 1.96% 15
2014
Q1 		$8.85M Sell
116,161
-871
-0.7% -$63.5K 1.98% 18
2013
Q4 		$8.43M Buy
117,032
+72
+0.1% +$5K 1.83% 26
2013
Q3 		$8.04M Sell
116,960
-14,357
-11% -$950K 1.82% 21
2013
Q2 		$8.32M Buy
+131,317
New +$8.54M 1.87% 22

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 16.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Philadelphia International Advisors's NVS Position: Q1 2015 in Review

Philadelphia International Advisors sold out of Novartis (NVS) in Q1 2015, closing a stake of 98,744 shares — an estimated $8.2M sold.

Philadelphia International Advisors first reported a position in NVS in Q2 2013 and held it in 7 quarters. The position peaked at $8.85M in Q1 2014. 940 funds tracked by Wall St. Rank hold NVS as of Q1 2015.

  • Philadelphia International Advisors reported no remaining Novartis position as of Q1 2015 after selling out during the quarter.
  • Philadelphia International Advisors sold 98,744 Novartis shares in Q1 2015, an estimated $8.2M.
  • Philadelphia International Advisors first reported a position in Novartis in Q2 2013 and held it in 7 quarters.
  • Philadelphia International Advisors's Novartis position peaked at $8.85M in Q1 2014.
  • 940 funds tracked by Wall St. Rank held Novartis as of Q1 2015.

Based on Philadelphia International Advisors's 13F filing for Q1 2015, filed 29 Apr 2015.